GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza

The ongoing threat from Influenza necessitates the development of new vaccine and adjuvant technologies that can maximize vaccine immunogenicity, shorten production cycles, and increase global vaccine supply. Currently, the most successful adjuvants for Influenza vaccines are squalene-based oil-in-w...

Descripción completa

Detalles Bibliográficos
Autores principales: Clegg, Christopher H., Roque, Richard, Perrone, Lucy A., Rininger, Joseph A., Bowen, Richard, Reed, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925208/
https://www.ncbi.nlm.nih.gov/pubmed/24551202
http://dx.doi.org/10.1371/journal.pone.0088979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925208/
https://www.ncbi.nlm.nih.gov/pubmed/24551202
http://dx.doi.org/10.1371/journal.pone.0088979

Ejemplares similares